JP6744542B2 - Method for culturing Lactobacillus Lactobacillus - Google Patents
Method for culturing Lactobacillus Lactobacillus Download PDFInfo
- Publication number
- JP6744542B2 JP6744542B2 JP2016029147A JP2016029147A JP6744542B2 JP 6744542 B2 JP6744542 B2 JP 6744542B2 JP 2016029147 A JP2016029147 A JP 2016029147A JP 2016029147 A JP2016029147 A JP 2016029147A JP 6744542 B2 JP6744542 B2 JP 6744542B2
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- medium
- culturing
- culture
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012258 culturing Methods 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 18
- 241000186660 Lactobacillus Species 0.000 title claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 52
- 241000894006 Bacteria Species 0.000 claims description 36
- 235000014655 lactic acid Nutrition 0.000 claims description 26
- 239000004310 lactic acid Substances 0.000 claims description 26
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 17
- 229940039696 lactobacillus Drugs 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 240000001417 Vigna umbellata Species 0.000 claims description 2
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 2
- 235000010716 Vigna mungo Nutrition 0.000 claims 1
- 239000002609 medium Substances 0.000 description 38
- 241000186605 Lactobacillus paracasei Species 0.000 description 17
- 235000013339 cereals Nutrition 0.000 description 14
- 239000000843 powder Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 208000002925 dental caries Diseases 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 229940017800 lactobacillus casei Drugs 0.000 description 9
- 244000199866 Lactobacillus casei Species 0.000 description 8
- 235000013958 Lactobacillus casei Nutrition 0.000 description 8
- 208000025157 Oral disease Diseases 0.000 description 8
- 208000030194 mouth disease Diseases 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000020183 skimmed milk Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000012136 culture method Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 208000028169 periodontal disease Diseases 0.000 description 6
- 201000001245 periodontitis Diseases 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000006872 mrs medium Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 101710188973 Catalase-4 Proteins 0.000 description 3
- 238000003794 Gram staining Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000007027 Oral Candidiasis Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 235000015192 vegetable juice Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000605909 Fusobacterium Species 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000605894 Porphyromonas Species 0.000 description 2
- 241000605862 Porphyromonas gingivalis Species 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 241000193987 Streptococcus sobrinus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- -1 oral ointment Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000003418 Lactobacillus casei ATCC 334 Nutrition 0.000 description 1
- 241001616242 Lactobacillus paracasei ATCC 334 Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001135235 Tannerella forsythia Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000021105 fermented cheese Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229940042125 oral ointment Drugs 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は、ラクトバチルス属乳酸菌の培養方法に関し、特に、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)の培養方法に関する。 The present invention relates to a method for culturing Lactobacillus lactic acid bacteria, and particularly to a method for culturing Lactobacillus paracasei (Lactobacillus paracasei) or Lactobacillus paracasei (Lactobacillus paracasei).
乳酸菌として、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)KO3株(NITE BP−771)、ラクトバチルス・カゼイ(Lactobacillus casei)YU3株(NITE BP−772)、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)YU4株(NITE BP−775)が知られている(特許文献1)。これらの乳酸菌は、う蝕菌、歯周病菌、カンジダ菌などの口内細菌に対して非常に高い抗菌力を有している。これらの乳酸菌は、果汁培地、野菜汁培地、牛乳培地、脱脂粉乳培地又は乳成分を含む培地で培養しても良いと記載されているが、実際には合成培地で培養されていた。 As lactic acid bacteria, Lactobacillus rhamnosus (Lactobacillus rhamnosus) KO3 strain (NITE BP-771), Lactobacillus casei (Lactobacillus casei) YU3 strain (NITE BP-772pIacUlusPUaclusLacBluacLus paraIsei paracasei). -775) is known (Patent Document 1). These lactic acid bacteria have a very high antibacterial activity against oral bacteria such as caries bacteria, periodontal disease bacteria, and Candida bacteria. It is described that these lactic acid bacteria may be cultivated in a fruit juice medium, a vegetable juice medium, a milk medium, a skimmed milk powder medium, or a medium containing milk components, but actually, they were cultured in a synthetic medium.
しかしながら、培養物を食品等に使用することを考慮すると、人工培地ではなく、天然成分からなる培地で培養することが求められていた。 However, considering that the culture is used for foods and the like, it has been required to culture in a medium composed of natural components instead of an artificial medium.
本発明は、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)の新たな培養方法を提供することを目的とする。 The present invention aims to provide a new method for culturing Lactobacillus rhamnosus, Lactobacillus casei, or Lactobacillus paracasei.
本発明者らは、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)の天然成分からなる培地について、検討を進めたところ、天然培地の中でも穀物を用いて培養すると、得られた培養物は非常に高い抗菌活性を有するという新たな知見を見出し、本発明を完成した。 The present inventors have conducted a study on a natural medium, which is a natural component of Lactobacillus rhamnosus, Lactobacillus casei, or Lactobacillus paracasei. Among them, the present invention has been completed by discovering a new finding that the obtained culture has a very high antibacterial activity when cultured using cereals.
すなわち、本発明は、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)を、穀物を含有する培地で培養する工程を有するラクトバチルス属乳酸菌の培養方法に関する。 That is, the present invention is to cultivate Lactobacillus lactobacillus in a medium containing a grain lactobacillus, in which Lactobacillus rhamnosus (Lactobacillus rhamnosus), Lactobacillus casei, or Lactobacillus paracasei is cultivated in a medium containing a grain lactobacillus. The present invention relates to a method for culturing lactic acid bacteria.
穀物が、大豆または米であることが好ましい。 The grain is preferably soybean or rice.
培地が、さらに糖類を含むことが好ましい。 It is preferable that the medium further contains a saccharide.
本発明の培養方法では、ラクトバチルス属の乳酸菌を、穀物を含有する培地で培養するため、培養物は非常に高い殺菌効果を奏する。 In the culturing method of the present invention, the lactic acid bacterium of the genus Lactobacillus is cultivated in a medium containing grains, so that the culture has a very high bactericidal effect.
本発明のラクトバチルス属乳酸菌の培養方法は、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)を、穀物を含有する培地で培養する工程を有することを特徴とする。 The method for culturing a lactic acid bacterium of the genus Lactobacillus of the present invention comprises a grain containing a medium containing Lactobacillus paracasei (Lactobacillus paracasei) or a culture medium containing Lactobacillus paracasei (Lactobacillus paracasei). It is characterized by having a process.
ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)属の中でも、KO3株(NITE BP−771)は、国際公開第2011/007584号に記載されているように、ヒト唾液中から分離された乳酸菌の一種であって、国際寄託されているものである。16S rRNAの塩基配列がラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)strain IDCC3201の塩基配列と1485/1485の間で100%の相同性を示し、グラム染色後の顕鏡下においてグラム陽性桿菌の様相を呈することから、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)と同定さている。KO3株の主な菌学的性質を以下に示す。
1)グラム陽性乳酸桿菌
2)ホモ型乳酸発酵
3)カタラーゼ陰性
4)芽胞形成能無し
5)好気条件下でも培養可
6)菌体外多糖類を産生
Among the genus Lactobacillus rhamnosus, the KO3 strain (NITE BP-771) is a type of lactic acid bacterium isolated from human saliva, as described in International Publication No. 2011/007584. , Those that have been internationally deposited. The nucleotide sequence of 16S rRNA exhibits 100% homology between the nucleotide sequence of Lactobacillus rhamnosus strain IDCC3201 and 1485/1485, and exhibits a Gram-positive rod-like appearance under a microscope after Gram staining. It has been identified as Lactobacillus rhamnosus. The main bacteriological properties of the KO3 strain are shown below.
1) Gram-positive lactobacillus 2) Homo-type lactic acid fermentation 3) Negative catalase 4) No ability to form spores 5) Cultivation under aerobic conditions 6) Production of extracellular polysaccharides
ラクトバチルス・カゼイ(Lactobacillus casei)属の中でも、YU3株は、国際公開第2011/007584号に記載されているように、ヒト唾液中から分離されたものであり、16S rRNAの塩基配列がラクトバチルス・カゼイ(Lactobacillus casei)ATCC 334の塩基配列と1485/1485の間で100%の相同性を示し、グラム染色後の顕鏡下においてクラム陽性桿菌の様相を呈することから、ラクトバチルス・カゼイ(Lactobacillus casei)と同定されている。YU3株の主な菌学的性質を以下に示す。
1)グラム陽性乳酸球菌
2)ホモ型乳酸発酵
3)カタラーゼ陰性
4)芽胞形成能 無し
5)好気条件下でも培養可
6)菌体外多糖類を産生
Among the genus Lactobacillus casei, the YU3 strain is isolated from human saliva as described in WO 2011/007584, and the nucleotide sequence of 16S rRNA is Lactobacillus. -Lactobacillus casei (Lactobacillus casei) shows 100% homology between the nucleotide sequence of Lactobacillus casei ATCC 334 and 1485/1485 and exhibits the appearance of a clam-positive bacillus under a microscope after Gram staining. casei). The main mycological properties of the YU3 strain are shown below.
1) Gram-positive lactococcus 2) Homo-type lactic acid fermentation 3) Negative catalase 4) No spore-forming ability 5) Can be cultured under aerobic conditions 6) Produces extracellular polysaccharides
ラクトバチルス・パラカゼイ(Lactobacillus paracasei)の中でも、YU4株は、国際公開第2011/007584号に記載されているように、ヒト唾液中から分離されたものであり、16S rRNAの塩基配列がラクトバチルス・パラカゼイ(Lactobacillus paracasei)strain DJ1 16S ribosomal RNA geneのPartial Sequenceと1477/1477(100%)の相同性を示し、グラム染色後の顕鏡下においてグラム陽性桿菌の様相を呈することから、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)と同定されている。YU4株の主な菌学的性質を以下に示す。
1)グラム陽性乳酸球菌
2)ホモ型乳酸発酵
3)カタラーゼ陰性
4)芽胞形成能 無し
5)好気条件下でも培養可
6)菌体外多糖類を産生
Among Lactobacillus paracasei (Lactobacillus paracasei), the YU4 strain was isolated from human saliva as described in WO 2011/007584, and the nucleotide sequence of 16S rRNA was Lactobacillus paracasei. Paracasei (Lactobacillus paracasei) strain shows the homology of Partial Sequence of DJ1 16S ribosomal RNA gene with 1477/1477 (100%) and shows the appearance of a Gram-positive bacillus under the microscope after Gram staining. (Lactobacillus paracasei). The main mycological properties of the YU4 strain are shown below.
1) Gram-positive lactococcus 2) Homo-type lactic acid fermentation 3) Negative catalase 4) No spore-forming ability 5) Can be cultured under aerobic conditions 6) Produces extracellular polysaccharides
培養の方法は、培地として穀物を含有する培地を使用する限り、特に限定されず、当業者に周知の乳酸菌の培養方法をそのまま適用することができる。穀物培地としては、例えば米、豆類、麦類、トウモロコシなどが挙げられる。穀物そのものだけでなく、米等の加工品を使用することもできる。豆類としては、大豆、小豆、エンドウ豆、ソラ豆などが挙げられ、麦類としては、小麦、大麦、ライ麦などが挙げられる。穀物を含む培地では、合成培地、たとえば乳培地と異なり、透明な培養物が得られる。培地中の穀物の含有量は0.1〜10重量%が好ましく、2〜10重量%がより好ましい。 The culturing method is not particularly limited as long as a medium containing cereals is used as the medium, and the lactic acid bacterium culturing method well known to those skilled in the art can be applied as it is. Examples of grain media include rice, beans, wheat, corn and the like. Not only the grains themselves, but also processed products such as rice can be used. Examples of the beans include soybean, red beans, peas, and beans, and examples of the wheat include wheat, barley, rye, and the like. Grain-containing media, unlike synthetic media such as milk media, give clear cultures. The content of grains in the medium is preferably 0.1 to 10% by weight, more preferably 2 to 10% by weight.
培養方法としては、培地が穀物を有していれば、特に限定されず、静置培養、pHを一定にした中和培養や、回分培養、連続培養などが挙げられる。 The culture method is not particularly limited as long as the medium has grains, and examples thereof include static culture, neutralization culture at a constant pH, batch culture, continuous culture, and the like.
培地は穀物を有していれば、果汁培地、野菜汁培地、牛乳培地、脱脂粉乳培地又は乳成分を配合しても良い。このような培地としては、脱脂乳を還元して加熱殺菌した還元脱脂乳培地、酵母エキスを添加した脱脂粉乳培地、MRS培地、GAM培地等を例示することができる。培養方法は、静置培養又はpHを一定にした中和培養や、回分培養及び連続培養等、菌体が良好に生育する条件であれば、特に制限はない。必要に応じて発酵促進物質、例えば糖類、澱粉、デキストリン、などの炭素源、酵母エキス、ペプトンなどの窒素源、ビタミン類、ミネラル類などを加えることができる。糖類としては、グルコース、アラビノース、ショ糖、乳糖、ソルビトール、フラクトースなどが挙げられる。なかでもグルコース、アラビノースなどを含有することが好ましい。糖類を使用する場合、使用量は培地中に0.1〜10重量%が好ましく、0.2〜5重量%がより好ましい。 If the medium has grains, it may be mixed with a fruit juice medium, a vegetable juice medium, a milk medium, a skimmed milk powder medium or a milk component. Examples of such a medium include a reduced skim milk medium obtained by reducing skim milk by heat sterilization, a skim milk powder medium containing yeast extract, an MRS medium, a GAM medium and the like. The culturing method is not particularly limited as long as the cells can grow well, such as static culturing or neutralization culturing at a constant pH, batch culturing and continuous culturing. If necessary, a fermentation promoting substance, for example, a carbon source such as sugar, starch, dextrin, a nitrogen source such as yeast extract and peptone, vitamins, minerals and the like can be added. Examples of saccharides include glucose, arabinose, sucrose, lactose, sorbitol, fructose and the like. Above all, it is preferable to contain glucose, arabinose and the like. When saccharides are used, the amount used is preferably 0.1 to 10% by weight in the medium, more preferably 0.2 to 5% by weight.
培養温度は特に限定されないが、20〜42℃が好ましく、25〜37℃がより好ましい。42℃を超えると、培養できなくなる傾向があり、20℃未満では、培養時間が長くなる傾向がある。 The culture temperature is not particularly limited, but is preferably 20 to 42°C, more preferably 25 to 37°C. If it exceeds 42°C, the culture tends to be impossible, and if it is less than 20°C, the culture time tends to be long.
培養時間も特に限定されないが、24〜500時間が好ましく、24〜240時間がより好ましく、72〜240時間がさらに好ましい。ヨーグルトなどの培養時間と比較して、長い時間の培養が必要である。 Although the culture time is not particularly limited, it is preferably 24 to 500 hours, more preferably 24 to 240 hours, and further preferably 72 to 240 hours. A long period of culture is required as compared with the culture time of yogurt or the like.
培養時の雰囲気も限定されないが、好気条件下であることが好ましい。 The atmosphere during culturing is not limited, but aerobic conditions are preferable.
本発明の培養方法によって得られた培養物は、そのまま使用することも、菌体または菌体培養物を、溶媒抽出することにより得られる各種溶剤抽出液、その希釈液、その濃縮液又はその乾燥末として使用することもできる。 The culture obtained by the culturing method of the present invention can be used as it is, or various solvent extracts obtained by solvent extraction of bacterial cells or bacterial cell cultures, diluted solutions thereof, concentrated solutions thereof, or dried solutions thereof. It can also be used as a powder.
抽出物を得るために用いられる抽出溶剤としては、極性溶剤、非極性溶剤のいずれをも使用することができ、これらを混合して用いることもできる。例えば、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;プロピレングリコール、ブチレングリコール等の多価アルコール類;アセトン、メチルエチルケトン等のケトン類;酢酸メチル、酢酸エチル等のエステル類;テトラヒドロフラン、ジエチルエーテル等の鎖状及び環状エーテル類;ポリエチレングリコール等のポリエーテル類;ヘキサン、シクロヘキサン、石油エーテル等の炭化水素類;ベンゼン、トルエン等の芳香族炭化水素類;ピリジン類等が挙げられ、このうち、酢酸エチル等のエステル類、エタノール等のアルコール類が好ましい。 As the extraction solvent used for obtaining the extract, either a polar solvent or a non-polar solvent can be used, and these can also be mixed and used. For example, water; alcohols such as methanol, ethanol, propanol, butanol; polyhydric alcohols such as propylene glycol and butylene glycol; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; tetrahydrofuran, diethyl ether Chain-like and cyclic ethers such as; polyethers such as polyethylene glycol; hydrocarbons such as hexane, cyclohexane and petroleum ether; aromatic hydrocarbons such as benzene and toluene; pyridines and the like. Esters such as ethyl acetate and alcohols such as ethanol are preferable.
抽出条件は、使用する溶剤によっても異なるが、例えば、培養液1質量部に対して1〜10質量部の溶剤を用い、0〜50℃、好ましくは25〜37℃の温度で、0.5時間〜3時間抽出するのが好ましい。 The extraction conditions vary depending on the solvent used, but for example, 1 to 10 parts by mass of the solvent is used with respect to 1 part by mass of the culture solution, at a temperature of 0 to 50° C., preferably 25 to 37° C. It is preferable to extract for 3 hours to 3 hours.
抽出物をそのまま用いることもできるが、当該抽出物を希釈、濃縮若しくは凍結乾燥した後、必要に応じて粉末又はペースト状に調製して用いることもできる。また、液々分配等の技術により、適宜精製して用いることもできる。 The extract can be used as it is, but after the extract is diluted, concentrated or lyophilized, it can be used in the form of powder or paste, if necessary. Further, it can be used after being appropriately purified by a technique such as liquid-liquid distribution.
培養物は、様々な用途に使用することができる。たとえば、口腔内疾患、デオドラントなどの化粧品などの用途が挙げられる。 The culture can be used for various purposes. For example, it may be used for oral diseases and cosmetics such as deodorant.
口腔内疾患とは、口腔内疾患の予防、改善又は治療剤におけるものであって、う蝕菌、歯周病菌及びカンジダ菌によって引き起こされる口腔内疾患をいい、例えば、う蝕症;歯肉炎、歯周炎等の歯周病、舌炎、鵞口瘡、口角炎等の口腔カンジダ症等が挙げられる。また、う蝕菌としては、ストレプトコッカス・ミュータンス(Streptococcus mutans)、ストレプトコッカス・ソブリナス(Streptococcus sobrinus)、歯周病菌としてはポルフィロモナス・ジンジバリス(Porphyromonas gingivalis)、プレボテラ・インターメディア(Prevotella intermedia)、トレポネーマ・デンティコーラ(Treponema denticola)、タンネレラ・フォーサイセンシス(Tannerella forsythensis)、アクチノバチルス・アクチノミセテムコミタンス(Actinobacillus actinomycetemcomitans)、フソバクテリウム・ヌクレアタム(Fusobacterium nucleatum)等が挙げられ、カンジダ菌としては、カンジダ・アルビカンス(Candida albicans)、カンジダ・グラブラータ(Candida glabrata)、カンジダ・トロピカリス(Candida tropicalis)等が挙げられる。 The oral disease is a preventive, ameliorating or therapeutic agent for oral diseases, and refers to oral diseases caused by caries bacterium, periodontitis bacterium and Candida, for example, caries; gingivitis, Periodontal diseases such as periodontitis, glossitis, oral thrush such as thrush, stomatitis and the like. Examples of the cariogenic bacteria include Streptococcus mutans, Streptococcus sobrinus, and periodontitis bacteria Porphyromonas tereplasma gingivalis (Porphyromonas terbella vulgaris).・Denticola (Treponema denticola), Tannerella forsythensis (Tanneraella forsythensis), actinobacillus actinomycetes bacillus Fructus bacillus actinomycetes bacillus, cinnamon bacillus, and so on. (Candida albicans), Candida glabrata, Candida tropicalis and the like.
本発明の培養方法によって得られた乳酸菌は、う蝕菌であるストレプトコッカス・ミュータンス(Streptococcus mutans)及びストレプトコッカス・ソブリナス(Streptococcus sobrinus)、歯周病菌であるポルフィロモナス・ジンジバリス(Porphyromonas gingivalis)及びカンジダ菌であるカンジダ・アルビカンス(Candida albicans)の何れに対しても増殖抑制効果を有する。また、口腔内の歯肉縁下プラークフォーマーとして知られるFusobacterium. nucleatum等のFusobacterium属細菌の増殖を抑制する作用を有する。 The lactic acid bacteria obtained by the culturing method of the present invention include Streptococcus mutans and Streptococcus sobrinus which are caries fungi, and Porphyromonas gingivalis porgyroisma (Porphyromonas gingivalis) that are periodontitis fungi. It has a growth inhibitory effect on any of Candida albicans which is a bacterium. Also known as Fusobacterium pneumoniae known as subgingival plaque former in the oral cavity. It has an action of suppressing the growth of Fusobacterium bacterium such as nucleatum.
したがって、当該乳酸菌の菌体若しくは菌体培養物又はこれらの抽出物は、口腔内疾患の予防、改善又は治療剤として、或いはう蝕菌、歯周病菌及びカンジダ菌の増殖抑制剤となり得る。斯かる口腔内疾患の予防、改善又は治療剤、う蝕菌、歯周病菌及びカンジダ菌の増殖抑制剤は、それ自体で、当該口腔内の病原微生物により引き起こされる、う蝕症、歯周病、口腔カンジダ症等の口腔内疾患の予防、改善又は治療のための、或いはう蝕菌、歯周病菌及びカンジダ菌の増殖抑制のための食品、医薬品、口腔用組成物等として使用でき、或いは食品、医薬品、口腔用組成物に配合するための素材として使用可能である。また、食品は、虫歯、歯周病、その他の口腔内感染症の予防・改善等をコンセプトとし、必要に応じてその旨を表示した健康食品、サプリメント若しくは特定保健用食品等の機能性食品とすることも可能である。 Therefore, the bacterial cells or bacterial cell cultures of the lactic acid bacteria or extracts thereof can be used as a preventive, ameliorating or therapeutic agent for oral diseases, or as a growth inhibitor for caries, periodontitis and Candida. Such a preventive, ameliorating or therapeutic agent for oral diseases, a caries bacterium, a periodontitis bacterium and a growth inhibitor of Candida bacterium, is itself caused by a pathogenic microorganism in the oral cavity, caries, periodontal disease , For preventing, improving or treating oral diseases such as oral candidiasis, or for inhibiting the growth of caries bacterium, periodontal disease bacterium and Candida bacterium, can be used as a pharmaceutical composition, oral composition, or the like, or It can be used as a material for incorporation into foods, pharmaceuticals, and oral compositions. In addition, foods are functional foods such as health foods, supplements or foods for specified health uses that show the concept, such as prevention and improvement of tooth decay, periodontal disease, and other oral infections, as necessary. It is also possible to do so.
医薬品として用いる場合の形態としては経口投与の形態が好ましく、その剤型は、例えば、液剤;錠剤、顆粒剤、細粒剤、粉剤、タブレット等の固形剤;或いは当該液剤又は固形剤を封入したカプセル剤、口腔用スプレー、トローチ等の様々な形態が挙げられる。このような種々の剤型の医薬製剤やサプリメントを調製するには、本発明の菌体や培養物の作用を妨げない範囲で、他の薬学的に許容される賦形剤、結合剤、増量剤、崩壊剤、界面活性剤、滑沢剤、分散剤、緩衝剤、保存剤、嬌味剤、香料、被膜剤、担体、希釈剤等を適宜組み合わせて用いることができる。斯かる経口投与用製剤として用いる場合の該製剤中の本発明の乳酸菌の菌体若しくは菌体培養物又はこれらの抽出物の含有量は、全組成中の1質量%〜50質量%、好ましくは10質量%〜20質量%である。 Oral administration is preferable as a form for use as a pharmaceutical, and the dosage form is, for example, a liquid form; a solid form such as tablets, granules, fine granules, powders, tablets; or the liquid form or solid form enclosed therein. Various forms such as capsules, oral sprays, troches and the like can be mentioned. In order to prepare pharmaceutical formulations and supplements of various dosage forms as described above, other pharmaceutically acceptable excipients, binders, and increasing amounts are used as long as they do not interfere with the action of the cells and culture of the present invention. Agents, disintegrants, surfactants, lubricants, dispersants, buffers, preservatives, flavoring agents, fragrances, film-forming agents, carriers, diluents and the like can be used in appropriate combination. When used as such a formulation for oral administration, the content of the lactic acid bacterium cell or cell culture of the present invention in the formulation or an extract thereof is 1% by mass to 50% by mass, preferably It is 10% by mass to 20% by mass.
食品として用いる場合の形態としては、果汁又は野菜汁飲料、炭酸飲料、茶系飲料、乳飲料、発酵乳、発酵果汁、発酵野菜汁、アルコール飲料、清涼飲料等の飲料や、ゼリー状食品や各種スナック類、焼き菓子、ケーキ類、チョコレート、ジャム、パン、ガム、飴、スープ類、漬物、佃煮等の各種食品の他、上述した経口投与製剤と同様の形態(錠剤、カプセル剤、シロップ等)のサプリメント等が挙げられる。 As a form when used as a food, fruit juice or vegetable juice beverage, carbonated beverage, tea-based beverage, milk beverage, fermented milk, fermented fruit juice, fermented vegetable juice, alcoholic beverage, beverage such as soft drink, jelly-like food and various Various foods such as snacks, baked goods, cakes, chocolates, jams, breads, gums, candy, soups, pickles, boiled vegetables, etc., as well as the above-mentioned oral administration preparations (tablets, capsules, syrups, etc.) Supplements and the like.
本発明の培養方法によって得られた培養物は、そのままヨーグルト、チーズ、味噌、醤油、漬物等の発酵食品となり、斯かる発酵乳やチーズを素材として使用し、虫歯や歯周病予防、改善用のパンやスナック菓子、ケーキ等にすることもできる。 The culture obtained by the culture method of the present invention is a yogurt, cheese, miso, soy sauce, fermented food such as pickles, etc. as it is, using such fermented milk or cheese as a material, to prevent caries and periodontal disease, for improvement It can also be made into bread, snacks, cakes, etc.
本発明の培養方法によって得られた乳酸菌の接種量は、一般には発酵用原料物質含有液1mL中に菌体が約1×106cells以上、好ましくは1×107cells前後含まれるものとなる量から選ばれるのが適当である。培養条件は、一般に、発酵温度20〜42℃程度、好ましくは25〜37℃程度、発酵時間5〜72時間程度から選ばれる。斯くして得られる乳酸発酵物は、カード状形態(ヨーグルト様形態)を有しており、このものはそのまま固形食品となり得る。該カード状形態の乳酸発酵物は、これを更に均質化することにより、所望の飲料形態とすることができる。 The inoculum of the lactic acid bacterium obtained by the culture method of the present invention is generally such that 1 mL of the fermentation raw material-containing liquid contains about 1×10 6 cells or more, preferably about 1×10 7 cells. Suitably selected from the amount. Cultivation conditions are generally selected from a fermentation temperature of about 20 to 42°C, preferably about 25 to 37°C, and a fermentation time of about 5 to 72 hours. The lactic acid fermented product thus obtained has a curd-like form (yogurt-like form), which can be directly used as a solid food. The curd-like lactic acid fermented product can be made into a desired beverage form by further homogenizing it.
本発明の培養方法によって得られた乳酸菌を、口腔内疾患の予防、改善又は治療剤等を口腔用組成物として用いる場合の具体的な形態としては、洗口剤、マウスウオッシュ、練歯磨、粉歯磨、水歯磨、口腔用軟膏剤、ゲル剤、錠剤、顆粒剤、細粒剤、グミゼリー、トローチ、タブレット、カプセル、キャンディー、チューインガム等が挙げられ、好ましくは、練歯磨、洗口剤、グミゼリー、トローチが挙げられる。 The lactic acid bacterium obtained by the culture method of the present invention, as a specific form when using a preventive, ameliorating or treating agent for oral diseases as an oral composition, a mouthwash, mouthwash, toothpaste, powder Toothpaste, water toothpaste, oral ointment, gel, tablets, granules, fine granules, gummy jelly, troches, tablets, capsules, candies, chewing gum and the like, preferably toothpaste, mouthwash, gummy jelly, There is a troche.
上記医薬品や食品への本発明の培養方法によって得られた乳酸菌の含有量は、特に限定されないが、一日投与量等に合わせて適宜調節すれば良いが、例えば剤型が液体の場合には、乳酸菌体濃度を1×106cells/ml〜1×108cells/mlとすることが好ましく、固体の場合には、1×107cells/g〜1×1010cells/gとすることが好ましい。 The content of the lactic acid bacterium obtained by the culture method of the present invention to the above-mentioned pharmaceuticals and foods is not particularly limited, and may be appropriately adjusted according to the daily dose etc., for example, when the dosage form is a liquid. The lactic acid bacterium concentration is preferably 1×10 6 cells/ml to 1×10 8 cells/ml, and in the case of a solid, 1×10 7 cells/g to 1×10 10 cells/g. Is preferred.
本発明の培養方法によって得られた乳酸菌を生菌として投与する場合は、成人一人当たり、1×108〜5×1010cfu/日投与することが好ましい。 When the lactic acid bacterium obtained by the culture method of the present invention is administered as a viable bacterium, it is preferably administered at 1×10 8 to 5×10 10 cfu/day per adult.
以下、実施例に基づき本発明を詳細に説明するが、本発明はこれらの実施例に限定されるものではない。 Hereinafter, the present invention will be described in detail based on examples, but the present invention is not limited to these examples.
実施例1
米タンパク「製品名プロファイン、ヤヱガキ醗酵技研(株)製」を2〜10%含み、必要に応じて炭素源としてグルコースまたはアラビノースを0.2〜5%付加したもの(残部は水)を加熱殺菌した培地にラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)KO3株(NITE BP−771)を接種し、30〜45℃で24〜240時間培養後、デキストリン等の賦形剤を液中に加え乾燥、粉砕したものを乳酸菌発酵粉末として得た。
Example 1
Rice protein "Product name Profine, manufactured by Yaegaki Fermentation Giken Co., Ltd." is contained in 2-10%, and glucose or arabinose is added as carbon source in an amount of 0.2-5% (the rest is water). A sterilized medium is inoculated with Lactobacillus rhamnosus KO3 strain (NITE BP-771), and after culturing at 30 to 45°C for 24 to 240 hours, an excipient such as dextrin is added to the liquid, dried and ground. The obtained product was obtained as a lactic acid bacterium fermentation powder.
実施例2〜3
大豆タンパク「製品名ハイニュート、不二製油(株)製」を2〜10%含み、必要に応じて炭素源としてグルコースまたはアラビノースを0.2〜5%付加したもの(残部は水)を加熱殺菌した培地にラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)KO3株(NITE BP−771)を接種し、30〜45℃で24〜240時間培養後、デキストリン等の賦形剤を液中に加え乾燥、粉砕したものを乳酸菌発酵粉末として得た。
Examples 2-3
Soy protein "Product name High New, manufactured by Fuji Oil Co., Ltd." is contained in 2 to 10%, and glucose or arabinose as a carbon source is added in an amount of 0.2 to 5% as needed (the balance is water). A sterilized medium is inoculated with Lactobacillus rhamnosus KO3 strain (NITE BP-771), and after culturing at 30 to 45°C for 24 to 240 hours, an excipient such as dextrin is added to the liquid, dried and ground. The obtained product was obtained as a lactic acid bacterium fermentation powder.
比較例1〜2
培地として、10%脱脂粉乳、0.5%酵母エキスを加熱殺菌した培地、または、MRS培地にラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)KO3株(NITE BP−771)を接種し、30〜45℃で24〜240時間培養後、デキストリン等の賦形剤を液中に加え乾燥、粉砕したものを乳酸菌発酵粉末として得た。
Comparative Examples 1-2
As a medium, 10% skim milk powder, a medium sterilized by heat with 0.5% yeast extract, or an MRS medium was inoculated with Lactobacillus rhamnosus KO3 strain (NITE BP-771), and the mixture was inoculated at 30 to 45°C. After culturing for 24 to 240 hours, an excipient such as dextrin was added to the liquid, dried and pulverized to obtain a lactic acid bacterium fermentation powder.
<抗菌活性の評価方法>
抗菌活性の指標として、ATP量を用い、以下の方法で評価した。各粉末の25%溶液100μlに対し,900μlのATP抽出試薬を入れ,室温で30分静置してATPを抽出した。各試料のATP量をATPアナライザー(TOA Electronics Ltd,Tokyo,Japan)を用いて計測した。なお,各条件につき同様の試料を各々8つずつ作製し,平均値±SDを算出した。
<Evaluation method of antibacterial activity>
The amount of ATP was used as an index of antibacterial activity and evaluated by the following method. ATP extraction reagent (900 μl) was added to 100 μl of 25% solution of each powder, and the mixture was allowed to stand at room temperature for 30 minutes to extract ATP. The ATP amount of each sample was measured using an ATP analyzer (TOA Electronics Ltd, Tokyo, Japan). Eight similar samples were prepared for each condition, and the average value ±SD was calculated.
図1に、比較例1および2で得た培養物のATP量をプロットしたが、MRS培地での培養物であっても、コントロールの値1100000に対して約1/10程度であった。図2に、実施例1〜3で得た培養物のATP量をプロットしたが、いずれもATP量が検出できないほど低減した。 In FIG. 1, the ATP amount of the cultures obtained in Comparative Examples 1 and 2 was plotted, and even for the culture in MRS medium, it was about 1/10 of the control value of 1100000. The ATP amount of the cultures obtained in Examples 1 to 3 was plotted in FIG. 2, and in all cases, the ATP amount decreased so that it could not be detected.
本発明の培養方法は、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)、ラクトバチルス・カゼイ(Lactobacillus casei)、または、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)の培養に適しており、得られた培養物は抗菌活性が高く、天然由来の培地を使用して培養しているため、得られた培養物は飲食物を含む様々な用途に適用することができる。
The culturing method of the present invention is suitable for culturing Lactobacillus rhamnosus (Lactobacillus rhamnosus), Lactobacillus casei, or Lactobacillus paracasei, and the obtained antibacterial activity is suitable as an antibacterial culture. Since the culture is high and the culture is performed using a naturally-derived medium, the obtained culture can be applied to various uses including food and drink.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016029147A JP6744542B2 (en) | 2016-02-18 | 2016-02-18 | Method for culturing Lactobacillus Lactobacillus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016029147A JP6744542B2 (en) | 2016-02-18 | 2016-02-18 | Method for culturing Lactobacillus Lactobacillus |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017143802A JP2017143802A (en) | 2017-08-24 |
JP6744542B2 true JP6744542B2 (en) | 2020-08-19 |
Family
ID=59680366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016029147A Active JP6744542B2 (en) | 2016-02-18 | 2016-02-18 | Method for culturing Lactobacillus Lactobacillus |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6744542B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108310962B (en) * | 2018-04-12 | 2020-10-20 | 北京昊业同宇科技有限公司 | Preparation method of composite microbial deodorant, deodorant and using method of deodorant |
TWI739078B (en) * | 2018-04-25 | 2021-09-11 | 日商曾根農場股份有限公司 | Composition for inhibiting fat accumulation |
JP7506963B2 (en) * | 2018-08-07 | 2024-06-27 | 株式会社ヤクルト本社 | Lactic acid bacteria medium |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5218041B2 (en) * | 2008-12-22 | 2013-06-26 | 福井県 | Rice lactic acid fermented food and drink and method for producing the same |
JP5697866B2 (en) * | 2009-11-05 | 2015-04-08 | 羽二重豆腐株式会社 | Method for producing lactic acid bacteria culture medium of soybean whey |
JP5918290B2 (en) * | 2014-03-19 | 2016-05-18 | 株式会社バイオジェノミクス | Method for producing lactic acid bacteria production substance, lactic acid bacteria production substance, allergic dermatitis inhibitor and systemic allergic reaction inhibitor |
EP3144382A4 (en) * | 2014-05-15 | 2017-10-25 | Ebara Foods Industry, Inc. | Method for producing lactic acid bacteria medium, method for culturing lactic acid bacteria using same, and lactic acid bacteria powder using lactic acid bacteria obtained by said culture method |
-
2016
- 2016-02-18 JP JP2016029147A patent/JP6744542B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017143802A (en) | 2017-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5645192B2 (en) | Preventive, ameliorating or treating agents for oral diseases | |
RU2743057C2 (en) | Use and methods of preventing and/or treating bad breath | |
AU2011290705B2 (en) | Probiotic composition for oral health | |
TWI563923B (en) | Ricebecue powder extract composition | |
JP5906011B2 (en) | Oral composition | |
WO2018123827A1 (en) | Fermented honey product and production method therefor | |
KR102287584B1 (en) | Composition comprising Lactobacillus sakei derived from Lonicera japonica Thunb. or cultured products thereof as a active ingredient | |
JP6744542B2 (en) | Method for culturing Lactobacillus Lactobacillus | |
JP5480864B2 (en) | Antibacterial agent and oral composition containing the same | |
JP6110240B2 (en) | Lactic acid bacteria, etc., and oral disease prevention materials and foods containing these | |
KR102320379B1 (en) | NOVEL STRAIN OF Lactobacillus plantarum AND USE THEREOF | |
KR20180071721A (en) | Composition for antioxidant or improving skin wrinkle comprising fermented Cudrania tricuspidata extract | |
WO2023282356A1 (en) | Oral composition and prophylactic or treatment method for diseases of the oral cavity | |
JP6293177B2 (en) | Oral composition | |
KR102343239B1 (en) | Novel strain of Lactobacillus plantarum having antimicrobial effect against pathogenic microorganism infection | |
KR20220094233A (en) | Composition with antibacterial, antioxidant, and anti-inflammatory activity containing ingredients converted to kimchi lactic acid bacteria and breast lactic acid bacteria in marigold extract | |
JP5744985B2 (en) | Antibacterial agent | |
JP2018100228A (en) | Antibacterial composition, food, and bacterial cell or bacterial cell culture or method for producing extract therefrom | |
KR20230102580A (en) | Preparing method for soymilk yogurt using Bacillus subtilis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200421 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200616 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200710 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6744542 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |